THERAVANCE BIOPHARMA ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY ZYMEWORKS FOR $17.00 PER SHARE IN CASH PLUS A CONTINGENT VALUE RIGHT

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/22/2026

1. USO
2. DHR
3. NVDA
4. SPY
5. AMD
6. GM
7. SMCI
8. NOW
9. EFX
10. IBM

Go back to THERAVANCE BIOPHARMA ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY ZYMEWORKS FOR $17.00 PER SHARE IN CASH PLUS A CONTINGENT VALUE RIGHT

Jones Trading Downgrades Theravance Biopharma (TBPH) to Hold

June 29, 2026 8:34 AM EDT

Jones Trading analyst Debanjana Chatterjee downgraded Theravance Biopharma (NASDAQ: TBPH) from Buy to Hold.

For an analyst ratings summary and ratings history on Theravance Biopharma click here. For more ratings news on Theravance Biopharma click here.

Shares of Theravance Biopharma closed at $17.63 yesterday.

... More